The Dopaminergic Polymorphisms in Psychomotor Retardation of Depression: A Pathway-based Imaging Genetics Association Study

Yixia Yin, Yonggui YuanEuropean 2017 · DOI

Abstract

Psychomotor retardation (PMR) is a hallmark feature of Major Depressive Disorder (MDD), characterized by a visible slowing of physical and mental activity. While dopamine is known to play a central role in PMR, the genetic and neurobiological mechanisms driving these symptoms remain unclear. This study investigates the association between polymorphisms in the dopaminergic pathway and cerebral blood flow (CBF) within the cortico-basal ganglia-thalamo-cortical (CBTC) circuitry. By analyzing 56 MDD patients (23 with PMR, 33 without), researchers identified significant genotype-by-PMR associations in the prefrontal cortex (PFC), striatum, and thalamus. Findings reveal that while increased CBF in the PFC is associated with reduced PMR severity, increased CBF in the striatum and thalamus appears to aggravate the condition, suggesting a complex regulatory balance within the dopaminergic system.

Introduction

Major Depressive Disorder (MDD) is a heterogeneous condition, and psychomotor retardation (PMR)—manifesting as slowed movement, speech, and thought—is among its most debilitating symptoms. Previous neuroimaging research has identified abnormal cerebral blood flow (CBF) within the cortico-basal ganglia-thalamo-cortical (CBTC) circuitry in patients exhibiting PMR. However, the link between a patient's genetic predisposition and these physiological changes has remained elusive.

This study utilizes an "imaging genetics" framework to bridge this gap. By examining Single Nucleotide Polymorphisms (SNPs) within the dopaminergic pathway, the researchers sought to determine how genetic variations influence the brain's hemodynamic environment to produce the clinical symptoms of PMR.

Methodology

Participant Selection and Genotyping

The study initially recruited 63 patients diagnosed with MDD at the Affiliated ZhongDa Hospital of Southeast University. Blood samples were collected for genotyping, targeting 92 SNPs across 10 genes related to the dopaminergic pathway. Following rigorous quality control, 15 SNPs across 8 candidate genes were selected for final analysis.

Neuroimaging and Statistical Analysis

Functional MRI (fMRI) was employed to measure CBF. After excluding participants with poor image quality or unmatched demographic data, the final cohort consisted of 56 patients: 23 in the PMR group and 33 in the non-PMR (NPMR) group. The researchers used mass univariate modeling to analyze the associations between genotypes, the presence of PMR, and regional CBF variations.

Key Results

Regional Associations

The study found that genotype-by-PMR associations were predominantly distributed across several key brain regions, including:

  • Bilateral prefrontal cortex (PFC)
  • Striatum and left thalamus
  • Temporal cortex and insular cortex
  • Right primary motor cortex, fusiform gyri, and lingual gyri

The PFC-Striatal Balance

A critical finding of the study was the divergent role of different brain regions in relation to symptom severity:

  1. Prefrontal Cortex (PFC): There was a significant negative correlation between CBF in the PFC and PMR severity. This suggests that higher activity in the PFC may serve as a compensatory mechanism or a "brake" that suppresses psychomotor slowing.
  2. Striatum and Thalamus: Conversely, CBF in the striatum and thalamus showed a positive correlation with PMR severity. Increased blood flow in these regions appears to aggravate the slowing of thought and movement.

Discussion

The results indicate that dopaminergic polymorphisms influence more than just the standard motor circuits; they affect broader networks responsible for cognition and emotion. The discovery of associations in the temporal and insular cortices suggests that PMR is a multi-dimensional phenomenon involving integrated neural systems.

This study provides evidence that genetic variations in dopamine processing directly shape the brain's functional state in depression. The "opposing forces" observed—where the PFC may suppress PMR while the striatum and thalamus exacerbate it—offer a new perspective on the neurobiology of depressive symptoms.

Limitations and Future Directions

While the study offers compelling insights, the authors note that the sample size (n=56) is relatively small for a genetic association study. Larger cohorts are required to validate these SNP-specific findings and establish definitive causality. Future research may explore whether these genetic and imaging markers can be used as biomarkers to predict patient response to dopaminergic antidepressants, potentially leading to more personalized treatment strategies for MDD.

Summary updated

Abstract

Introduction Several lines of evidence implicate dopamine is involved in the psychomotor retardation (PMR) in major depressive disorder (MDD). Besides, abnormal cerebral blood flow (CBF) of PMR was also found in the cortico-basal ganglia-thalamo-cortical (CBTC) circuitry. We hypothesize that the polymorphisms of the dopaminergic pathway should be associated the abnormal CBF in the CBTC circuitry. Objective To investigate the association of the polymorphisms throughout the dopaminergic pathway with the cerebral blood flow (CBF) of PMR in MDD. Methods The blood sample of 63 patients (23 PMR, 40 NPMR) were collected for genotyping the dopaminergic polymorphisms (92 SNPs from10 genes). After quality controlling, 15 SNPs in 8 candidate genes were entered into the mass univariate modeling analysis. For the statistical analysis, patients with unqualified fMRI image and unmatched demographic data were ruled out. Consequently 56 patients (23 PMR, 33 NPMR) were taken into the statistical analysis. Results Genotype-by PMR associations with the CBF differences predominately distributed in bilateral prefrontal cortex (PFC), temporal cortex, and striatum, the left thalamus, the right primary motor cortex, insular cortex, fusiform gyri, and lingual gyri. There were significant negative correlation between the CBF of the PFC and the PMR severity. However, the CBF of the striatum and the thalamus were positively correlated with the PMR severity. Conclusions The polymorphisms of dopaminergic pathway are associated with not only CSTC circuitry, but also some other brain regions involving in cognition and emotion controlling. While the increased CBF of PFC might suppress PMR, the increased CBF of striatum and thalamus adversely aggravate PMR.
BibTeX
@inproceedings{yin2017dopaminergic,
  author = {Yixia Yin and Yonggui Yuan},
  title = {{The Dopaminergic Polymorphisms in Psychomotor Retardation of Depression: A Pathway-based Imaging Genetics Association Study}},
  booktitle = {European},
  year = {2017},
  doi = {10.1016/j.eurpsy.2017.01.1989},
}
Figure